ClinicalTrials.Veeva

Menu

Post-stroke Motor Rehabilitation Using Functional Near-infrared Spectroscopy-based Brain-computer-interface (fNIRS-PROMOTE)

A

Axem Neurotechnology

Status and phase

Unknown
Early Phase 1

Conditions

Hemiparesis

Treatments

Device: Axem Home

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05258591
2020A016951

Details and patient eligibility

About

Chronic stroke survivors suffering from weaknesses or movement difficulties in their hand/arm are provided a system to aid in at-home rehabilitation for 6 weeks. This rehabilitation system includes a headband that measures and provides feedback from the brain during rehabilitation, together with tablet-based software. Throughout the 6 week rehabilitation period (as well as in a follow-up session 1 month afterwards) several assessments are taken to understand the effect of this rehabilitation on participant's movement abilities, as well as their brain activity.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 - 90 years
  • 6 months - 5 years since most recent stroke
  • Upper-extremity Fugl-Meyer motor function (FMA-UE) score ≤56
  • Able to follow simple commands
  • Fluency in English
  • Not currently receiving therapy for the upper extremity

Exclusion criteria

  • Visual impairment that would interfere with visualization of the therapy interface (score >0 on the visual subscale of the NIH stroke scale)
  • Montreal Cognitive Assessment (MoCA) Score ≥10
  • History of significant physical disability prior to most recent stroke
  • Open wounds on the scalp
  • Unable or unwilling to remove hair braids or head coverings which interfere with the Axem Home device efficacy.
  • Inability to follow training instructions for at-home BCI system.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Axem Home
Experimental group
Description:
Patients receive at-home access to Axem Home system for duration of the study period.
Treatment:
Device: Axem Home

Trial contacts and locations

1

Loading...

Central trial contact

Christopher Friesen, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems